.png){kind=logo}
Amanta Healthcare Limited is all set for its initial public offering (IPO) for which the price band has been set at Rs 120 and Rs 126 per share. The issue price at Rs 10 per equity share will be open for subscription on Monday, 1 September 2025, and will close on Wednesday, 3 September 2025. The company has also scheduled its allocation to anchor investors for Friday, August 29.
The Amanta Healthcare IPO has created a buzz among retail investors this season. The IPO is being closely watched by investors, given the company’s established presence in sterile formulations and a robust export network.
Amanta Healthcare is known for its strong presence in the pharmaceutical sector. The floor price and the cap price of the offer are 12 times and 12.60 times the face value of the shares, respectively. Investors can bid for a minimum of 119 shares per lot, and in multiples of 119 thereafter.
As per SEBI regulations, the allocation has been divided across investor categories. Up to 50% of the issue is reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and at least 35% is earmarked for retail investors.
The allotment is expected to be finalized on Thursday, September 4, 2025. Refunds to unsuccessful bidders will begin on Friday, September 5, and shares will be credited to investors’ demat accounts on the same day.
Market experts closely monitor the Amanta IPO GMP before the listing day. Amanta Healthcare shares are likely to debut on both the BSE and NSE on Monday, September 8, 2025.
The issue consists of 1 crore fresh equity shares. The company intends to use the proceeds to increase its manufacturing capacity. The company is spending around Rs 70 crore for establishing a new SteriPort production line in Hariyala and Rs 30.13 crore on another line for small-volume parenterals (SVP) at the same location. Remaining funds will be used for general corporate purposes.
Investors are curious about the Amanta Healthcare IPO Size and future projections. Beeline Capital Advisors is managing the book-running process, while MUFG Intime India is acting as the registrar.
Also Read: Vikram Solar IPO Allotment: Investors Await Shares, GMP Cools Despite Strong Demand
Amanta Healthcare, founded in 1994, manufactures sterile liquid formulations and medical devices, distributing across India and exporting to 21 countries. In FY25, it posted Rs 276.09 crore revenue and a 189% jump in profit to Rs 10.5 crore; its listed peer is Denis Chem Lab Ltd (P/E 15.92).
The Amanta Healthcare Ltd Share Price is expected to reflect strong demand post-listing. Its product range includes IV fluids, ophthalmic solutions, respiratory care items, and eye lubricants. The company also employs advanced ABFS and ISBM technologies to ensure packaging safety and quality.
With its strong industry presence, growing product range, and improving profitability, Amanta Healthcare's IPO has attracted large investor interest. The increased capacity for expanding coverage of community customers and concentration on exports should improve growth prospects for Amanta Healthcare, making this issue an intriguing proposition for retail and institutional investors.
